SEBI Approves IPO Plans Of Symbiotec Pharmalab, Vishvaraj Environment, SAEL; Jindal Supreme Withdraws IPO

The Securities and Exchange Board of India has approved the IPO offer documents of Symbiotec Pharmalab Ltd., Vishvaraj Environment Ltd., and SAEL Industries Ltd. The market regulator issued its 'observation letter' to the filings, which means final nod in SEBI parlance, during the week ending March 27. In addition, Jindal Supreme India Ltd. has withdrawn its IPO plan.

Shah Investor's Home Ltd., Prasol Chemicals Ltd. and NoPaperForms Solutions Ltd. IPO also received nod from SEBI.

There are currently 26 draft IPO offer documents under review by SEBI, including SBI Funds Management Ltd., Deepa Jewellers Ltd., and Moneyview Ltd.

This is a developing story.